Latest Sustainability News

EBR Systems has secured final CMS approval for Transitional Pass-Through reimbursement for its WiSE CRT System, effective October 1, 2025, enhancing hospital adoption prospects in the U.S.

Environmental Clean Technologies Limited (ECT) has requested a voluntary suspension of its shares on the ASX as it prepares to announce a significant acquisition and capital raising.

ReNerve Limited has launched its Empliq tissue product range in the US, marking a strategic expansion into the growing dermal and amniotic tissue market. The launch complements its existing nerve repair portfolio and sets the stage for further growth.

Emyria secures a multi-year funding agreement with Medibank to support its Treatment-Resistant Depression program, marking a first for insurer-backed psychotherapy in Australia.

Regis Healthcare reveals a funding update amid government changes, projecting modest EBITDA growth despite a funding gap and rising wage costs.

Altamin Limited has announced a $6.46 million capital raising via a pro rata entitlement offer to fund development of its lithium-potash Lazio Project and zinc-lead Gorno Project in Italy. The majority shareholder Victor Smorgon Group has committed strongly, underpinning the raise.

Memphasys Limited has secured $0.84 million through a placement and announced a rights issue to raise up to $1.12 million, sharply cutting operating costs to accelerate commercialisation and manufacturing scale-up of its Felix™ bioseparation system.

The Environmental Group's subsidiary EGL Baltec has landed a $9.3 million contract to supply critical gas turbine exhaust systems for an 800MW power plant in the Dominican Republic, reinforcing its role in renewable energy support.

Kingsland Minerals’ scoping study confirms the Leliyn Graphite Project in the Northern Territory as a low-cost, globally competitive graphite producer with strong financial metrics and growth potential.

ADX Energy has secured a pivotal court ruling that allows it to resume drilling and testing at its Welchau-1 well in Austria, overcoming environmental objections and strengthening its exploration prospects.

LTR Pharma has acquired a one-third equity stake in LevOmega Pty Ltd at no cost to shareholders, positioning itself in the growing pharmaceutical-grade omega-3 sector. This strategic move complements LTR’s existing intranasal pharmaceutical portfolio and aligns with its innovation-driven growth strategy.

Brazilian Critical Minerals has reported sustained high-grade rare earth element recovery from its in-situ recovery trials at the Ema Project, with pregnant leach solution grades exceeding 5,700 ppm TREO and strong magnet rare earth oxide content.